These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 12766081)
1. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. McGuire PG; Jones TR; Talarico N; Warren E; Das A Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model. Das A; Boyd N; Jones TR; Talarico N; McGuire PG Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Colombo ES; Menicucci G; McGuire PG; Das A Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513 [TBL] [Abstract][Full Text] [Related]
4. A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes. Navaratna D; Menicucci G; Maestas J; Srinivasan R; McGuire P; Das A FASEB J; 2008 Sep; 22(9):3310-7. PubMed ID: 18559877 [TBL] [Abstract][Full Text] [Related]
5. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis. Zhu F; Jia S; Xing G; Gao L; Zhang L; He F DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166 [TBL] [Abstract][Full Text] [Related]
6. Regulation and role of urokinase plasminogen activator in vascular remodelling. Tkachuk V; Stepanova V; Little PJ; Bobik A Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711 [TBL] [Abstract][Full Text] [Related]
7. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy. Basu A; Menicucci G; Maestas J; Das A; McGuire P Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4974-81. PubMed ID: 19443721 [TBL] [Abstract][Full Text] [Related]
9. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases. Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889 [TBL] [Abstract][Full Text] [Related]
10. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression. Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810 [TBL] [Abstract][Full Text] [Related]
11. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C; Yu J; Huang S Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542 [TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
13. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression. Lulli M; Cammalleri M; Granucci I; Witort E; Bono S; Di Gesualdo F; Lupia A; Loffredo R; Casini G; Dal Monte M; Capaccioli S Biochem Biophys Res Commun; 2017 Aug; 490(3):977-983. PubMed ID: 28666875 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529 [TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
17. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Satofuka S; Ichihara A; Nagai N; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Itoh H; Oike Y; Ishida S Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):422-9. PubMed ID: 17197563 [TBL] [Abstract][Full Text] [Related]
18. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. Guo Y; Higazi AA; Arakelian A; Sachais BS; Cines D; Goldfarb RH; Jones TR; Kwaan H; Mazar AP; Rabbani SA FASEB J; 2000 Jul; 14(10):1400-10. PubMed ID: 10877833 [TBL] [Abstract][Full Text] [Related]
19. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669 [TBL] [Abstract][Full Text] [Related]